Pharma

Transforming health through business and innovation.

Moderna's bird flu vaccine has a problem

Moderna's bird flu vaccine has a problem

By

UpdatedFebruary 27, 2025

Off-brand weight loss drug makers are suing the FDA again

By

PublishedFebruary 25, 2025

Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs

By

UpdatedFebruary 25, 2025

Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27%

Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27%

By

UpdatedFebruary 25, 2025

Eli Lilly is making even more doses of Zepbound cheaper

Eli Lilly is making even more doses of Zepbound cheaper

By

PublishedFebruary 25, 2025

Theranos founder Elizabeth Holmes' fraud conviction is upheld by an appeals court

Theranos founder Elizabeth Holmes' fraud conviction is upheld by an appeals court

By

PublishedFebruary 24, 2025

The Ozempic shortage is over

The Ozempic shortage is over

By

UpdatedFebruary 21, 2025

Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

By

PublishedFebruary 21, 2025

Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss

Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss

By

UpdatedFebruary 20, 2025

Big Pharma and drug middlemen donated record money to get Trump on their side

Big Pharma and drug middlemen donated record money to get Trump on their side

By

PublishedFebruary 19, 2025

Hims & Hers is getting into the at-home blood testing business

Hims & Hers is getting into the at-home blood testing business

By

PublishedFebruary 19, 2025

A new HIV prevention drug could get FDA approval this year

A new HIV prevention drug could get FDA approval this year

By

UpdatedFebruary 18, 2025

A bird flu vaccine for chickens is on its way

A bird flu vaccine for chickens is on its way

By

UpdatedFebruary 18, 2025

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

By

PublishedFebruary 14, 2025

Ozempic, Eliquis, Keytruda: The 9 top-selling drugs of 2024

Ozempic, Eliquis, Keytruda: The 9 top-selling drugs of 2024

By

PublishedFebruary 14, 2025

Ozempic helps people drink less alcohol, study says

Ozempic helps people drink less alcohol, study says

By

UpdatedFebruary 12, 2025

Ozempic and other weight loss drugs may be linked to conditions that could lead to blindness, study says

Ozempic and other weight loss drugs may be linked to conditions that could lead to blindness, study says

By

PublishedFebruary 11, 2025

Hims & Hers' off-brand weight loss drugs made a Super Bowl splash. Here's what to know

By

UpdatedFebruary 10, 2025

Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup

Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup

By

PublishedFebruary 7, 2025

Big drama around the Hims & Hers Super Bowl ad is making its way to the FDA

Big drama around the Hims & Hers Super Bowl ad is making its way to the FDA

By

PublishedFebruary 6, 2025

Advertisement